Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 29, 2021
Source ID
10.1007/s40291-021-00550-6

Entities

People

  • Jeffrey S. Miller
  • Martin Felices
  • Shee Kwan Phung

Organizations

  • National Cancer Institute
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech